Giving GSH directly as a supplement by mouth does not consistently help raise glutathione levels because it is negatively affected by digestion
On the other hand, statistically significant increases were observed in L-carnitine treated medakas in spermidine levels (ratio: 1.3), -aminobutyric acid (GABA) (ratio: 1.6), allantoic acid (ratio: 2.0), and dihydroxyacetone phosphate (ratio: 1.5), while 2-aminoadipic acid (ratio: 0.7), 3-methylhistidine (ratio: 0.6), -Glu-Cys (ratio: 0.7), and 5-oxoproline (ratio: 0.7) decreased (Table 1)
Recent studies by Amminger, Bell, and Patrick have found that increasing Omega-3s in the diet is associated with improvements in people with ASD, particularly in hyperactivity and repetitive behaviors, as well as cognitive and motor skills, concentration, eye contact, sociability, and sleep
Antioxidants like glutathione are endogenous substances (substances naturally produced by your body) that take free radicals to task
By modulating pain pathways and reducing inflammation, BPC-157 may provide significant relief from knee pain, enhancing overall comfort and quality of life
Thats a gap the FDA is right to point at, and its a gap that legal compounding plus real trials would start to close